⏳ Fetching live dividend data...
Home › Calculator › CVSI Dividend Calculator 2026
CV Sciences, Inc. · OTC
Price: $0.03 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in CVSI → $6.193398908306598e+29M in 10 years · $51,610,901,550,155,970,000,000,000,000,000,000.00/month
CV Sciences, Inc. operates as a life science company in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets plant-based dietary supplements and hemp-based cannabidiol (CBD) products under the PlusCBD, ProCBD, HappyLane, CV Acute, CV Defense, and PlusCBD Pet brand names in various health care sectors, including nutraceutical, beauty care, specialty foods, and pet products. It sells its products through its websites, internet sales, elect distributors, brick and mortar retailers, and select e-tailers. The Specialty Pharmaceutical segment focuses on developing and commercializing cannabinoids to treat medical indications. This segment is developing drug candidate CVSI-007 that combines CBD and nicotine in treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CVSI position with:
Real after-tax yield depends on where you live and how you hold CVSI.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 6666.67% | 6663.87% | $666,667 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 5666.67% | 5663.87% | $566,667 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 5333.34% | 5330.54% | $533,334 / yr |
| 🇬🇧 UK ISA | 0% | 6666.67% | 6663.87% | $666,667 / yr |
| 🇬🇧 UK Taxable | 8.75% | 6083.34% | 6080.54% | $608,334 / yr |
| 🇨🇦 TFSA | 0% | 6666.67% | 6663.87% | $666,667 / yr |
| 🇨🇦 CA Taxable | 25% | 5000.00% | 4997.20% | $500,000 / yr |
| 🇦🇺 Super (pension) | 15% | 5666.67% | 5663.87% | $566,667 / yr |
| 🇦🇺 AU Taxable | 30% | 4666.67% | 4663.87% | $466,667 / yr |
| 🇩🇪 DE Taxable | 26.375% | 4908.34% | 4905.54% | $490,834 / yr |
| 🇫🇷 FR Taxable | 30% | 4666.67% | 4663.87% | $466,667 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
CVSI pays quarterly — 4 times per year. Next ex-div: TBD.
How CVSI compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CVSI sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2025-02-18 | 500,000 | $0.04 | $18.8K | ||
| A-Award | 2025-02-18 | 2,350,000 | $0.04 | $88.1K | ||
| A-Award | 2025-02-18 | 3,000,000 | $0.04 | $112.5K | ||
| A-Award | 2025-02-18 | 500,000 | $0.04 | $18.6K | ||
| A-Award | 2024-06-20 | 500,000 | $0.05 | $27.0K | ||
| A-Award | 2024-06-20 | 500,000 | $0.05 | $27.0K | ||
| A-Award | 2024-06-20 | 2,350,000 | $0.05 | $126.9K | ||
| A-Award | 2024-06-20 | 3,000,000 | $0.05 | $162.0K | ||
| A-Award | 2023-03-15 | 2,500,000 | $0.04 | $100.0K | ||
| A-Award | 2023-03-15 | 1,250,000 | $0.04 | $50.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CVSI dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →